These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7649952)

  • 1. Generic bioequivalence.
    Weinberg HA
    J Am Acad Child Adolesc Psychiatry; 1995 Jul; 34(7):834-5. PubMed ID: 7649952
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in Adverse Event Reporting Rates of Therapeutic Failure Between Two Once-daily Extended-release Methylphenidate Medications in Canada: Analysis of Spontaneous Adverse Event Reporting Databases.
    Park-Wyllie L; van Stralen J; Castillon G; Sherman SE; Almagor D
    Clin Ther; 2017 Oct; 39(10):2006-2023. PubMed ID: 28988700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing stimulant medication for attention-deficit/hyperactivity disorder.
    Wender EH
    Pediatr Rev; 2001 Jun; 22(6):183-90. PubMed ID: 11389305
    [No Abstract]   [Full Text] [Related]  

  • 4. QuilliChew ER--extended-release chewable methylphenidate tablets.
    Med Lett Drugs Ther; 2016 May; 58(1495):68-9. PubMed ID: 27192619
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylphenidate transdermal system.
    Mays DA; Findling R
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder.
    Biederman J; Spencer T
    J Atten Disord; 2002; 6 Suppl 1():S101-7. PubMed ID: 12685524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate and ADHD: influence of age, IQ and neurodevelopmental status.
    Mayes SD; Crites DL; Bixler EO; Humphrey FJ; Mattison RE
    Dev Med Child Neurol; 1994 Dec; 36(12):1099-107. PubMed ID: 7525394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
    Moungnoi P; Maipang P
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder.
    Fitzpatrick PA; Klorman R; Brumaghim JT; Borgstedt AD
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):226-34. PubMed ID: 1564023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full-day ADHD symptom control that "lasts from home to homework".
    Pediatr Nurs; 2000; 26(6):634-5. PubMed ID: 12026370
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose methylphenidate treatment of attention deficit hyperactivity disorder in a preschooler.
    Lipkin PH; Butz AM; Cozen MA
    J Child Adolesc Psychopharmacol; 2003; 13(1):103-6. PubMed ID: 12804131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discussion comment on the contribution by E. Schulz and H. Remschmidt: Stimulant therapy of hyperkinetic syndrome in childhood and adolescence].
    Bachmann P
    Z Kinder Jugendpsychiatr; 1991 Jun; 19(2):111-3; author reply 114-6. PubMed ID: 1887691
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical inquiries. Does increasing methylphenidate dose aid symptom control in ADHD?
    Ibay AD; Bascelli LM; Graves RS; Hill J
    J Fam Pract; 2003 May; 52(5):400, 403. PubMed ID: 12737774
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylphenidate revisited.
    Med Lett Drugs Ther; 1988 May; 30(765):51-2. PubMed ID: 3362094
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of methylphenidate on reward strength in boys with attention-deficit hyperactivity disorder.
    Wilkison PC; Kircher JC; McMahon WM; Sloane HN
    J Am Acad Child Adolesc Psychiatry; 1995 Jul; 34(7):897-901. PubMed ID: 7649960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate-Induced Raynaud Phenomenon Developed After Increasing Methylphenidate in an Adult With Attention-Deficit Hyperactivity Disorder.
    Monteerarat Y; Pariwatcharakul P
    J Clin Psychopharmacol; 2019; 39(2):178-179. PubMed ID: 30811376
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects and noneffects of methylphenidate in children with mental retardation and ADHD.
    Handen BL; Breaux AM; Janosky J; McAuliffe S; Feldman H; Gosling A
    J Am Acad Child Adolesc Psychiatry; 1992 May; 31(3):455-61. PubMed ID: 1592777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'.
    Olders H
    J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of methylphenidate for attention deficit hyperactivity disorder.
    Lexchin J
    CMAJ; 1991 May; 144(10):1209-10. PubMed ID: 2025813
    [No Abstract]   [Full Text] [Related]  

  • 20. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.